Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States
Tóm tắt
Từ khóa
Tài liệu tham khảo
Centers for Disease Control and Prevention. Immunization Schedule for Adults (19 Years of Age and Older). [accessed 2019 Jan 15]. https://www.cdc.gov/vaccines/schedules/hcp/adult.html
Centers for Disease Control and Prevention. Vaccination Coverage Among Adults in the United States National Health Interview Survey 2016. [accessed 2019 Jan 15]. https://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/pubs-resources/NHIS-2016.html
United States Census Bureau. Projected Population by Age Sex Race and Hispanic Origin: 2014 to 2060 [accessed 2019 Jan 15]. https://www.census.gov/data/datasets/2014/demo/popproj/2014-popproj.html
Acosta A. Cost-effectiveness of pertussis vaccine substitution for tetanus booster in prevention of pertussis in adults 65 years and older. Presentation to the Advisory Committee on Immunization Practices (ACIP). Atlanta (GA): US Department of Health and Human Services, CDC; 2012.
Centers for disease control and prevention. Influenza vaccination coverage estimates for persons 6 months and older by state HHS region and the United States National Immunization Survey-Flu (NIS-Flu) and Behavioral Risk Factor Surveillance System (BRFSS) 2010-11 through 2016-17 influenza seasons. 2017. [accessed 2018 Feb 20]. https://www.cdc.gov/flu/fluvaxview/reportshtml/trends/index.html
Centers for Disease Control and Prevention. AdultVaxView Vaccination Coverage Among Adults in the United States National Health Interview Survey 2016. 2018. [accessed 2018 Feb 20]. https://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/NHIS-2016.html
Bresee J, Reed C, Kim IK, Finelli L, Fry A, Chaves SS, Burns E, Gargiullo P, Jernigan D, Cox N, et al. Estimated influenza illnesses and hospitalizations averted by influenza vaccination — United States, 2012–13 influenza season. MMWR Morb Mortal Wkly Rep. 2013;62:997–1000.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance report Emerging Infections Program Network Streptococcus pneumoniae. 2013. Atlanta (GA): Centers for Disease Control and Prevention; 2013.
Centers for Disease Control and Prevention. Estimated Influenza Illnesses and Hospitalizations Averted by Vaccination — United States 2014–15 Influenza Season. 2015. [accessed 2016 Apr 20]. http://www.cdc.gov/flu/about/disease/2014-15.htm
Centers for Disease Control and Prevention. Estimated Influenza Illnesses Medical Visits Hospitalizations and Deaths Averted by Vaccination in the United States. 2017. [accessed 2019 Mar 28]. https://www.cdc.gov/flu/about/disease/2015-16.htm
Reed C, Kim IK, Singleton JA, Chaves SS, Flannery B, Finelli L, Fry A, Burns E, Gargiullo P, Jernigan D, et al. Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep. 2014;63(49):1151–54.
Centers for disease control and prevention. Past Seasons Vaccine Effectiveness Estimates 2018. [accessed 2019 Dec 12]. https://www.cdc.gov/flu/vaccines-work/past-seasons-estimates.html
Centers for Disease Control and Prevention. 2017 Behavioral risk factor surveillance system survey data and documentation. [accessed 2019 Jan 15]. https://www.cdc.gov/brfss/annual_data/annual_2017.html
Zostavax prescribing information. [accessed 2019 Jan 15]. https://www.merck.com/product/usa/pi_circulars/z/zostavax/zostavax_pi2.pdf
Centers for Disease Control and Prevention. Vaccine recommendations and guidelines of the ACIP: vaccine-specific recommendations (by date published). 2019. [accessed 2020 Jan 14]. https://www.cdc.gov/vaccines/hcp/acip-recs/recs-by-date.html
Shingrix prescribing information. [accessed 2019 Jan 15]. https://gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF
Patterson BJ, Cheng WY, Trofa AF, Duchesneau A, Macheca M, Masseria C, Duh MS A claims-based analysis of hepatitis A, B and A/B vaccination series completion and compliance among US adults. ISPOR 22nd Annual International Meeting. Boston, MA, USA, 2017.
Arias E, Heron M, Xu J. United States life tables, 2014. Natl Vital Stat Rep. 2017;66.
U.S. Department of Health & Human Services. National Adult Immunization Plan. 2016. [accessed 2019 April 10]. https://www.hhs.gov/sites/default/files/nvpo/national-adult-immunization-plan/naip.pdf
Centers for Disease Control and Prevention. Strategies for Increasing Adult Vaccination Rates. 2016. [accessed 2019 Mar 7]. https://www.cdc.gov/vaccines/hcp/adults/for-practice/increasing-vacc-rates.html
Akinbosoye OETM, Grana J, Macpherson C. Factors associated with zostavax abandonment. Am J Pharm Benefits. 2016;8:84–89.
National quality forum. Priority setting for healthcare performance measurement: addressing performance measure gaps for adult immunizations. 2014. [accessed 2019 Apr 10]. https://www.qualityforum.org/Publications/2014/08/Priority_Setting_for_Healthcare_Performance_Measurement__Addressing_Performance_Measure_Gaps_for_Adult_Immunizations.aspx
HEDIS 2020 Volume 2. Appendix 1: summary table of measures product lines and changes. 2020. [accessed 2020 May 6]. https://www.ncqa.org/wp-content/uploads/2019/07/20190701_HEDIS_2020_Measures_Summary_of_Changes.pdf
Navarro-Torné A, Hanrahan F, Kerstiëns B, Aguar P,LM. Public health–driven research and innovation for next-generation influenza vaccines, European Union. Emerg Infect Dis. 2019;25(2). https://doi.org/10.3201/eid2502.180359
Matanock A Considerations for PCV13 use among adults ≥65 years old and a summary of the evidence to recommendations framework. Advisory committee on immunization practices june 2019 meeting. 2019. [accessed 2019 Nov 13]. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2019-06/Pneumococcal-2-Matanock-508.pdf
Havers F. Tdap and Td: summary of Work Group considerations and proposed policy options. 2019. [accessed 2019 Dec 11]. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2019-10/Pertussis-03-Havers-508.pdf